Mitarbeiterinnen und Mitarbeiter

Ziegler MC, Naidoo K, Chapel A, Nkotwana S, Mann J, Mncube Z, Ismael N, Goulder P, Ndung'u T, Altfeld M, Thobakgale CF (2021). HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype. AIDS. 35/2021; PubMed

Ziegler MC, Nelde A, Weber JK, Schreitmüller CM, Martrus G, Huynh T, Bunders MJ, Lunemann S, Stevanovic S, Zhou R, Altfeld M (2020). HIV-1 induced changes in HLA-C*03 :  04-presented peptide repertoires lead to reduced engagement of inhibitory natural killer cell receptors. AIDS. 34/2020; PubMed

Ziegler MC, Grañana FB, Garcia-Beltran WF, Schulze Zur Wiesch J, Hoffmann C, Rechtien A, Lunemann S, Altfeld M (2018). Stable Frequencies of HLA-C*03:04/Peptide-Binding KIR2DL2/3+ Natural Killer Cells Following Vaccination. Front Immunol. 9/2018; PubMed

Chapel A, Garcia-Beltran WF, Hölzemer A, Ziegler M, Lunemann S, Martrus G, Altfeld M (2017). Peptide-specific engagement of the activating NK cell receptor KIR2DS1. Sci Rep. 7/2017; PubMed

Körner C, Simoneau CR, Schommers P, Granoff M, Ziegler M, Hölzemer A, Lunemann S, Chukwukelu J, Corleis B, Naranbhai V, Kwon DS, Scully EP, Jost S, Kirchhoff F, Carrington M, Altfeld M (2017). HIV-1-Mediated Downmodulation of HLA-C Impacts Target Cell Recognition and Antiviral Activity of NK Cells. Cell Host Microbe. 22/2017; PubMed

Lunemann S, Martrus G, Hölzemer A, Chapel A, Ziegler M, Körner C, Garcia Beltran W, Carrington M, Wedemeyer H, Altfeld M (2016). Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function. J Hepatol. 65/2016; PubMed

Behrens K, Triviai I, Schwieger M, Tekin N, Alawi M, Spohn M, Indenbirken D, Ziegler M, Müller U, Alexander WS, Stocking C (2016). Runx1 downregulates stem cell and megakaryocytic transcription programs that support niche interactions. Blood. 127/2016; PubMed

Herglotz J, Unrau L, Hauschildt F, Fischer M, Kriebitzsch N, Alawi M, Indenbirken D, Spohn M, Müller U, Ziegler M, Schuh W, Jäck HM, Stocking C (2015). Essential control of early B-cell development by Mef2 transcription factors. Blood. 127/2016; PubMed

Triviai I, Ziegler M, Bergholz U, Oler AJ, Stübig T, Prassolov V, Fehse B, Kozak CA, Kröger N, Stocking C (2014). Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis. Proc Natl Acad Sci U S A. 111/2014; PubMed

Niebuhr B, Kriebitzsch N, Fischer M, Behrens K, Günther T, Alawi M, Bergholz U, Müller U, Roscher S, Ziegler M, Buchholz F, Grundhoff A, Stocking C (2013). Runx1 is essential at two stages of early murine B-cell development. Blood. 122/2013; PubMed

Rodenburg M, Fischer M, Engelmann A, Harbers SO, Ziegler M, Löhler J, Stocking C (2006). Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity. J Virol. 81/2007; PubMed

Grez M, Zörnig M, Nowock J, Ziegler M (1991). A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells. J Virol. 65/1991; PubMed

Akgün E, Ziegler M, Grez M (1991). Determinants of retrovirus gene expression in embryonal carcinoma cells. J Virol. 65/1991; PubMed